An article about our clinical-grade induced pluripotent stem cells custom manufacturing service was published in the Nikkei, a leading business newspaper in Japan with about 3 million readership, on May 15, 2020.

https://www.nikkei.com/article/DGXMZO59172930V10C20A5LKA000/